Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
#Events

Category: Uncategorized

Tobacco Regulatory Litigation & Administrative Law: Altria Sues US FDA in Federal Court Demanding Complete Overhaul of Premarket Tobacco Application (PMTA) Framework – Citing Statutory 180-Day Deadlines and Market Distortions Across the $22 Billion Sector

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, Altria Group, Inc. (NYSE: MO)—the manufacturer of Marlboro cigarettes in the United States—alongside two... Read more

Tags: #Global Trends

Cell Therapy Safety & Translational Immunology: Novartis and Bristol Myers Squibb Pause Autoimmune CAR-T Trials Following Three Fatal IEC-HS Cases – Scrutinizing Hyper-Proliferation Risks in Rapid-Manufacturing Platforms

03/09/2026 Published by Pharma Biz

Key Development In early September 2026, biopharmaceutical leaders Novartis AG (SIX: NOVN / NYSE: NVS) and Bristol Myers Squibb (NYSE:... Read more

Category: Uncategorized

Tags: #Global Trends

Biomanufacturing Decentralization & Personalized Medicine: ARPA-H Commits $125 Million to Fund GIVE Program – Accelerating Automated, Point-of-Care RNA Drug Production and 24-Hour Quality Control Lot Release

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, the Advanced Research Projects Agency for Health (ARPA-H), an agency operating within the U.S.... Read more

Category: Uncategorized

Tags: #Global Trends

Biomanufacturing Footprint & Industrial Rationalization: Novartis Signals 130 Redundancies in Switzerland Amid Biologics Realignment, Relocating Laboratories to Main Basel Campus while Divesting Small-Scale Manufacturing

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, Swiss multinational pharmaceutical leader Novartis AG (SIX: NOVN / NYSE: NVS) announced a structural... Read more

Category: Uncategorized

Tags: #Global Trends

Tobacco Control & Behavioral Health Economics: Health Strategy and Policy Institute Proposes Complete Point-of-Sale Display Ban as 40.9% of Retailers Violate Regulations – Projecting 5 Million Fewer Smokers and VND 4 Trillion Annual Healthcare Savings

03/09/2026 Published by Pharma Biz

Key Development On September 1, 2026, the Health Strategy and Policy Institute (HSPI) under the Ministry of Health of Vietnam... Read more

Category: Uncategorized

Tags: #Vietnam

Out-of-Hospital Emergency Governance & Clinical Ethics: Department of Medical Examination and Treatment (MOH) Orders Urgent Inquiry into Alleged Price-Gouging of Private Ambulance and Vasopressor Drugs in Thanh Hoa – Exposing Regulatory Gaps in End-of-Life Patient Transport

03/09/2026 Published by Pharma Biz

Key Development On the afternoon of September 2, 2026, the Department of Medical Examination and Treatment under the Ministry of... Read more

Category: Uncategorized

Tags: #Vietnam

Healthcare Legislative Governance: Vietnamese Government Submits Omnibus Bill Amending 5 Core Health & Welfare Statutes to National Assembly Standing Committee – Targeting Systemic Reforms Across Pharmacy, Medical Treatment, Population, Children, and Disability Laws

03/09/2026 Published by Pharma Biz

Key Development On the afternoon of September 3, 2026, the Standing Committee of the National Assembly of Vietnam (NASC) officially... Read more

Category: Uncategorized

Tags: #Vietnam

TREELINE–ROCHE COMBINATION STRATEGY PUTS BCL6 DEGRADATION AT THE CENTER OF NEXT-GENERATION LYMPHOMA THERAPY

03/09/2026 Published by HealthBiz

Key Development Treeline Biosciences has entered a clinical trial collaboration and drug-supply agreement with Roche to evaluate its investigational BCL6... Read more

Category: Uncategorized

Tags: #Global Trends